Performance

The overall Trust position remains stable in all the areas except for the 4 hour emergency care transit time standard of 95%. The Trust has worked closely with the regulators, system partners and the staff towards delivering sustained improvements in this key delivery area. Whilst the year end position for the 4 hour transit time standard was at 84.6%, the month of March ended with 77.6% of our patients being discharged, admitted or transferred within 4 hours. Quarter 4 2017/18 was particularly difficult with emergency patient flows at the Trust which was consistent with the national picture. We provide services from two locations: Hillingdon Hospital in Hillingdon and Mount Vernon Hospital in Northwood.

Annual Report and Accounts 2017/2018 (6.9MB, pdf)

Last year in 2017/2018

  • 109,374 attendances were made to our Accident & Emergency department and Minor Injuries Unit
  • 4,660 babies were born in our Maternity Unit
  • 375,580 attendances were made as outpatients
  • 26,130 admissions were made for emergency treatment across all parts of the Trust
  • 25,963 admissions were made for planned operations and day surgery

Referral to Treatment

The Trust ended the year with a performance of 91.1% against a target of 92%. This was particularly related to the emergency Care pressures experienced over Q3 and Q4 2017/18 resulting in cancellation of elective procedures to create inpatient capacity. The service teams continue to increase capacity at specialty level in response to demand based on clinical priority and chronological wait. The Trust RTT model is being developed further in light of the increasing levels of demand in 2017/18 to support the delivery of the standard.

Clostridium difficile

The Trust reported 19 cases for 2017/18. There were 2 lapses in care during 2017/18 (at time of report as several cases remain under review with commissioners) against a threshold of 8 (lapses in care). This reflects an increase of 7 total cases when compared with 2016/17. Clostridium difficile infection rates remain however below the London and national average. An increase has been noted regionally and nationally.

A multidisciplinary Root Cause Analysis (RCA) investigation is undertaken for all cases of Trust attributed C. difficile, with the Consultant in charge of care, the Consultant Microbiologist, Lead Nurse Infection Prevention and Control, Ward Sister and responsible Matron forming a panel as part of the process. All RCAs are reviewed by the Director of Infection Prevention and Control and all reports are presented to the Clinical Commissioning Group for review for any lapses in care.

Cancer Performance

The Trust successfully achieved all of the cancer access targets for the fifth successive year. The close tracking of each patient at tumor site level with a strong multi-disciplinary approach has been a key enabler for this success. The Trust remains committed towards delivering a sustained performance for our patients in this area. However, key risks around diagnostic capacity and increased referrals remain. These are mitigated with tumor site review of demand and capacity.

Infection control

performance indicators